The structural biology of type I viral membrane fusion (original) (raw)
Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem.69, 531–569 (2000). A comprehensive review of the known properties of the influenza virus haemagglutinin and the structural basis of these properties. ArticleCASPubMed Google Scholar
Sollner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H. & Rothman, J. E. A protein assembly–disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell75, 409–418 (1993). CASPubMed Google Scholar
Weissenhorn, W. et al. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol.16, 3–9 (1999). ArticleCASPubMed Google Scholar
Crennell, S., Takimoto, T., Portner, A. & Taylor, G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nature Struct. Biol.7, 1068–1074 (2000). This paper presents the structure of the HN attachment protein of NDV and provides a basis for interpreting data that link this protein to the fusion activity of the F protein. CASPubMed Google Scholar
Chen, L. et al. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure9, 255–266 (2001). Together with influenza HA, the structure presented in this paper is one of only two that provide information on the pre-fusion conformation of a type I viral fusion protein. CASPubMed Google Scholar
Wilson, I. A., Skehel, J. J. & Wiley, D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 (tm) resolution. Nature289, 366–373 (1981). CASPubMed Google Scholar
Chen, J. et al. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell95, 409–417 (1998). CASPubMed Google Scholar
Bullough, P. A., Hughson, F. M., Skehel, J. J. & Wiley, D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature371, 37–43 (1994). CASPubMed Google Scholar
Chen, J., Skehel, J. J. & Wiley, D. C. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc. Natl Acad. Sci. USA96, 8967–8972 (1999). CASPubMedPubMed Central Google Scholar
Durrer, P. et al. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J. Biol. Chem.271, 13417–13421 (1996). CASPubMed Google Scholar
Skehel, J. J. et al. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl Acad. Sci. USA79, 968–972 (1982). CASPubMedPubMed Central Google Scholar
Kozlov, M. M. & Chernomordik, L. V. A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements. Biophys. J.75, 1384–1396 (1998). CASPubMedPubMed Central Google Scholar
Gruenke, J. A., Armstrong, R. T., Newcomb, W. W., Brown, J. C. & White, J. M. New insights into the spring-loaded conformational change of influenza virus hemagglutinin. J. Virol.76, 4456–4466 (2002). CASPubMedPubMed Central Google Scholar
Godley, L. et al. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell68, 635–645 (1992). CASPubMed Google Scholar
Wharton, S. A., Skehel, J. J. & Wiley, D. C. Studies of influenza haemagglutinin-mediated membrane fusion. Virology149, 27–35 (1986). CASPubMed Google Scholar
Ruigrok, R. W. H. et al. Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology155, 484–497 (1986). CASPubMed Google Scholar
Stegmann, T. & Helenius, A. in Viral Fusion Mechanisms (ed. Bentz, J.) 89–111 (CRC Press, Boca Raton, Florida, USA, 1993). Google Scholar
Ward, C. W. & Dopheide, T. A. Influenza virus haemagglutinin. Structural predictions suggest that the fibrillar appearance is due to the presence of a coiled-coil. Aust. J. Biol. Sci.33, 441–447 (1980). CASPubMed Google Scholar
Buckland, R. & Wild, F. Leucine zipper motif extends. Nature338, 547 (1989). CASPubMed Google Scholar
Chambers, P., Pringle, C. R. & Easton, A. J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol.71, 3075–3080 (1990). CASPubMed Google Scholar
Chen, L. et al. Cloning, expression, and crystallization of the fusion protein of Newcastle disease virus. Virology290, 290–299 (2001). CASPubMed Google Scholar
Calder, L. J. et al. Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology271, 122–131 (2000). CASPubMed Google Scholar
Dutch, R. E., Hagglund, R. N., Nagel, M. A., Paterson, R. G. & Lamb, R. A. Paramyxovirus fusion (F) protein: a conformational change on cleavage activation. Virology281, 138–150 (2001). CASPubMed Google Scholar
Paterson, R. G., Russell, C. J. & Lamb, R. A. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology270, 17–30 (2000). CASPubMed Google Scholar
Wharton, S. A., Skehel, J. J. & Wiley, D. C. Temperature dependence of fusion by Sendai virus. Virology271, 71–78 (2000). CASPubMed Google Scholar
Lamb, R. A. Paramyxovirus fusion: a hypothesis for changes. Virology197, 1–11 (1993). CASPubMed Google Scholar
Bousse, T., Takimoto, T., Gorman, W. L., Takahashi, T. & Portner, A. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology204, 506–514 (1994). CASPubMed Google Scholar
Tanabayashi, K. & Compans, R. W. Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. Virology70, 6112–6118 (1996). CAS Google Scholar
Stone-Hulslander, J. & Morrison, T. G. Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J. Virol.73, 3630–3637 (1999). CASPubMedPubMed Central Google Scholar
Bousse, T., Takimoto, T. & Portner, A. A single amino acid change enhances the fusion promotion activity of human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Virology209, 654–657 (1995). CASPubMed Google Scholar
Deng, R. et al. Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion. Virology253, 43–54 (1999). CASPubMed Google Scholar
Takimoto, T., Taylor, G. L., Connaris, H. C., Crennell, S. J. & Portner, A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus–cell membrane fusion. J. Virol.76, 13028–13033 (2002). CASPubMedPubMed Central Google Scholar
Yao, Q., Hu, X. & Compans, R. W. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J. Virol.71, 650–656 (1997). CASPubMedPubMed Central Google Scholar
Stone-Hulslander, J. & Morrison, T. G. Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J. Virol.71, 6287–6295 (1997). CASPubMedPubMed Central Google Scholar
Earl, P. L., Broder, C. C., Doms, R. W. & Moss, B. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. J. Virol.71, 2674–2684 (1997). CASPubMedPubMed Central Google Scholar
Earl, P. L. et al. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol.68, 3015–3026 (1994). CASPubMedPubMed Central Google Scholar
Edinger, A. L. et al. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains. J. Virol.73, 4062–4073 (1999). CASPubMedPubMed Central Google Scholar
Moore, J. P., McKeating, J. A., Weiss, R. A. & Sattentau, Q. J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science250, 1130–1142 (1990). Google Scholar
Poignard, P., Fouts, T., Naniche, D., Moore, J. P. & Sattentau, Q. J. Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation. J. Exp. Med.183, 473–484 (1996). CASPubMed Google Scholar
Weissenhorn, W. et al. Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc. Natl Acad. Sci. USA94, 6065–6069 (1997). CASPubMedPubMed Central Google Scholar
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. & Wiley, D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature387, 426–430 (1997). CASPubMed Google Scholar
Yang, Z. N. et al. The crystal structure of the SIV gp41 ectodomain at 1.47 (tm) resolution. J. Struct. Biol.126, 131–144 (1999). This paper describes a high-resolution study of the fusion-core structure of simian immunodeficiency virus (SIV), which expands on the information that has been reported in parallel studies of HIV. CASPubMed Google Scholar
Thali, M., Furman, C., Helseth, E., Repke, H. & Sodroski, J. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. J. Virol.66, 5516–5524 (1992). CASPubMedPubMed Central Google Scholar
Sattentau, Q. J. & Moore, J. P. Conformational changes induced in the human immunodeficiency virus envelope glycoproteins by soluble CD4 binding. J. Exp. Med.174, 407–415 (1991). CASPubMed Google Scholar
Thali, M. et al. Characterization of human immunodeficiency virus type 1 (HIV-1) gp120 neutralization epitopes exposed upon gp120–CD4 binding. J. Virol.67, 3978–3988 (1993). CASPubMedPubMed Central Google Scholar
Sattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F. & Poignard, P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol.67, 7383–7393 (1993). CASPubMedPubMed Central Google Scholar
Myszka, D. G. et al. Energetics of the HIV gp120–CD4 binding reaction. Proc. Natl Acad. Sci. USA97, 9026–9031 (2000). CASPubMedPubMed Central Google Scholar
Kwong, P. D. et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature420, 678–682 (2002). This article describes a thermodynamic study of the binding of gp120 to CD4, which indicates that very large conformational changes accompany the binding event. CASPubMed Google Scholar
Binley, J. M. et al. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol.74, 627–643 (2000). CASPubMedPubMed Central Google Scholar
Chan, D. C., Fass, D., Berger, J. M. & Kim, P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell89, 263–273 (1997). CASPubMed Google Scholar
Kwong, P. D., Wyatt, R., Sattentau, Q. J., Sodroski, J. & Hendrickson, W. A. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J. Virol.74, 1961–1972 (2000). CASPubMedPubMed Central Google Scholar
Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature393, 648–659 (1998). CASPubMedPubMed Central Google Scholar
Wild, C., Oas, T., McDanal, C., Bolognesi, D. & Matthews, T. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl Acad. Sci. USA89, 10537–10541 (1992). CASPubMedPubMed Central Google Scholar
Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B. & Matthews, T. J. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl Acad. Sci. USA91, 9770–9774 (1994). CASPubMedPubMed Central Google Scholar
Rapaport, D., Ovadia, M. & Shai, Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J.14, 5524–5531 (1995). CASPubMedPubMed Central Google Scholar
Lambert, D. M. et al. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl Acad. Sci. USA93, 2186–2191 (1996). CASPubMedPubMed Central Google Scholar
Yao, Q. & Compans, R. W. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology223, 103–112 (1996). CASPubMed Google Scholar
Lu, M., Blacklow, S. C. & Kim, P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol.2, 1075–1082 (1995). CASPubMed Google Scholar
Kilby, J. M. et al. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nature Med.4, 1302–1307 (1998). This work describes early clinical data, which indicate that new medicines might emerge from our growing understanding of the molecular basis of viral membrane fusion. CASPubMed Google Scholar
Rimsky, L. T., Shugars, D. C. & Matthews, T. J. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol.72, 986–993 (1998). CASPubMedPubMed Central Google Scholar
Chan, D. C., Chutkowski, C. T. & Kim, P. S. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl Acad. Sci. USA95, 15613–15617 (1998). CASPubMedPubMed Central Google Scholar
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A. & Kim, P. S. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell99, 103–115 (1999). CASPubMed Google Scholar
Russell, C. J., Jardetzky, T. S. & Lamb, R. A. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J.20, 4024–4034 (2001). This paper decribes an important study of conformational changes in the F protein, which were probed using the inhibitory effects of N- and C-peptides. CASPubMedPubMed Central Google Scholar
Young, J. K., Li, D., Abramowitz, M. C. & Morrison, T. G. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions. J. Virol.73, 5945–5956 (1999). CASPubMedPubMed Central Google Scholar
Furuta, R. A., Wild, C. T., Weng, Y. & Weiss, C. D. Capture of an early fusion-active conformation of HIV-1 gp41. Nature Struct. Biol.5, 276–279 (1998). CASPubMed Google Scholar
Melikyan, G. B. et al. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol.151, 413–423 (2000). CASPubMedPubMed Central Google Scholar
Koshiba, T. & Chan, D. C. The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions. J. Biol. Chem.278, 7573–7579 (2003). CASPubMed Google Scholar
Kraulis, P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr.24, 946–950 (1991). Google Scholar
Merritt, E. A. & Bacon, D. J. Raster3D: photorealistic molecular graphics. Meth. Enzymol.277, 505–524 (1997). CAS Google Scholar
Nicholls, A. GRASP: graphical representation and analysis of surface properties. Biophys. J.64, A116 (1993). Google Scholar
Wild, T. F., Malvoisin, E. & Buckland, R. Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol.72, 439–442 (1991). CASPubMed Google Scholar
Ebata, S. N., Cote, M. -J., Yong Kang, C. & Dimock, K. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology183, 437–441 (1991). CASPubMed Google Scholar
Hu, X., Ray, R. & Compans, R. W. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J. Virol.66, 1528–1534 (1992). CASPubMedPubMed Central Google Scholar
Bagai, S. & Lamb, R. A. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenxza virus 3 or Newcastle disease virus. J. Virol.69, 6712–6719 (1995). CASPubMedPubMed Central Google Scholar
Ito, M. et al. Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation. J. Virol.71, 9855–9858 (1997). CASPubMedPubMed Central Google Scholar
Ito, M., Nishio, M., Komada, H., Ito, Y. & Tsurudome, M. An amino acid in the heptad repeat 1 domain is important for the haemagglutinin-neuraminidase-independent fusing activity of simian virus 5 fusion protein. J. Gen. Virol.81, 719–727 (2000). CASPubMed Google Scholar
Tsurudome, M. et al. Hemagglutinin-neuraminidase-independent fusion activity of simian virus 5 fusion (F) protein: difference in conformation between fusogenic and nonfusogenic F proteins on the cell surface. J. Virol.75, 8999–9009 (2001). CASPubMedPubMed Central Google Scholar
Sergel, T. A., McGinnes, L. W. & Morrison, T. G. A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion. J. Virol.74, 5101–5107 (2000). CASPubMedPubMed Central Google Scholar
Seth, S., Vincent, A. & Compans, R. W. Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion. J. Virol.77, 167–178 (2003). CASPubMedPubMed Central Google Scholar
McGinnes, L. W., Reitter, J. N., Gravel, K. & Morrison, T. G. Evidence for mixed membrane topology of the Newcastle disease virus fusion protein. J. Virol.77, 1951–1963 (2003). CASPubMedPubMed Central Google Scholar
Wyde, P. R. et al. CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats. Antiviral Res.38, 31–42 (1998). CASPubMed Google Scholar
Aulabaugh, A. et al. Inhibition of respiratory syncytial virus by a new class of chemotherapeutic agents. Drugs of the Future25, 287–294 (2000). Google Scholar
Andries, K. et al. R170591, a new antiviral with picomolar activity against respiratory syncytial virus. Antiviral Res.50, S1–S94 (2001). Google Scholar
Debnath, A. K., Radigan, L. & Jiang, S. Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1. J. Med. Chem.42, 3203–3209 (1999). CASPubMed Google Scholar
Jiang, S., Zhao, Q. & Debnath, A. K. Peptide and non-peptide HIV fusion inhibitors. Curr. Pharm. Des.8, 563–580 (2002). CASPubMed Google Scholar
Zhou, G. et al. The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core. Bioorg. Med. Chem.8, 2219–2227 (2000). CASPubMed Google Scholar
Smith, B. J., Lawrence, M. C. & Colman, P. M. Modelling the structure of the fusion protein from human respiratory syncytial virus. Protein Eng.15, 365–371 (2002). CASPubMed Google Scholar
McKimm-Breschkin, J. L. et al. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob. Agents Chemother.40, 40–46 (1996). CASPubMedPubMed Central Google Scholar
Blick, T. J. et al. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en. Virology214, 475–484 (1995). CASPubMed Google Scholar
Colman, P. M. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci.3, 1687–1696 (1994). CASPubMedPubMed Central Google Scholar
Greengard, O., Poltoratskaia, N., Leikina, E., Zimmerberg, J. & Moscona, A. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J. Virol.74, 11108–11114 (2000). CASPubMedPubMed Central Google Scholar
Neurath, A. R., Strick, N., Jiang, S., Li, Y. Y. & Debnath, A. K. Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of 'dead-end' gp41 six-helix bundles. BMC Infect. Dis.2, 6 (2002). PubMedPubMed Central Google Scholar
Baker, K. A., Dutch, R. E., Lamb, R. A. & Jardetzky, T. S. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell3, 309–319 (1999). This paper describes the structure of the complex of N- and C-peptides from the paramyxovirus F protein and links this family of viruses to HIV. CASPubMed Google Scholar
Zhao, X., Singh, M., Malashkevich, V. N. & Kim, P. S. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc. Natl Acad. Sci. USA97, 14172–14177 (2000). CASPubMedPubMed Central Google Scholar